The Safety of Vardenafil in Patients Undergoing Cardiac Surgery

Completed · Phase 1

Conditions studied: Ischemia-reperfusion Injury.

In brief

The purpose of this study is to evaluate the safety of vardenafil in cardiac surgery patients.

Key facts

Study ID

NCT01260285

Run by

McGuire Research Institute

People needed

10

Starts

2010-12-01

Expected to finish

2011-10-01

Last updated by the study team

2011-11-04

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• undergoing cardiac surgery

You may not qualify if…

• emergent surgery
• recent MI in past 7 days prior to surgery
• ejection fraction < 35%
• creatinine > 2.0
• prior CVA
• severe COPD
• recent use of nitrates (within past 48 hours prior to surgery)
• prior CABG
• pregnancy

Where it is running

• McGuire VAMC — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.